If you’re a child in Medicaid, you already have a more difficult life than average ahead of you. Children in Medicaid programs have nearly twice …

Awhile back, a Beyond Blue reader asked me to address the …

Bipolar disorder has been the focus of attention in …

What if your new drug has an unwanted side effect that’s going to impact sales if it becomes widely known? Well, in the case of …

Shares of Vanda Pharmaceuticals, the makers of Fanapt (iloperidone), surged today after the U.S. Food and Drug Administration sprang a surprise drug approval for Fanapt …

If you haven’t been hiding under a rock in the past few years, you’ve probably heard about Zyprexa (olanzapine). It’s an atypical antipsychotic psychiatric medication …

A rebuke to years of off-label marketing by pharmaceutical companies behind closed doctors’ doors was just published in the form of a journal article demonstrating …

During a routine review of the safety of Johnson & Johnson’s atypical antipsychotic Risperdal and Eli Lilly’s Zyprexa, a panel of experts consulting with the …

A New York City federal judge ordered drug company Eli Lilly to unseal confidential documents concerning the popular antipsychotic drug Zyprexa (Olanzapine) this past …

My old hometown newspaper, The News Journal (Wilmington, Del.) had a nice write-up of Seroquel’s big explosion in …

A letter to the editor in today’s The Boston Globe by Janet Wozniak suggests that since the U.S. Food and Drug Administration (FDA) approved …

I’m not real sure why this was making headlines yesterday, but apparently the fact that the FDA required a black box warning on older antipsychotic …